SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-022326
Filing Date
2021-02-16
Accepted
2021-02-12 21:51:04
Documents
1
Group Members
IRA SCOTT GREENSPANJOSHUA R. LAMSTEIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm216627d1_sc13g.htm SC 13G 59005
  Complete submission text file 0001104659-21-022326.txt   60672
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Subject) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92033 | Film No.: 21631634
SIC: 2834 Pharmaceutical Preparations

Mailing Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170 9176743889
HCFP/Capital Partners 18B-1 LLC (Filed by) CIK: 0001821940 (see all company filings)

IRS No.: 352615715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G